Teijin Limited

04/18/2022 | Press release | Distributed by Public on 04/17/2022 20:04

Teijin and JCR Pharmaceuticals Co., Ltd. Cease JTR-161 Dental Pulp Stem Cell Research[Teijin] (PDF: 137.8 KB)